Comparison of extended-release sildenafil with standard sildenafil in a randomized placebo-controlled study
Abstract
INTRODUCTION
Sildenafil citrate (Viagra) is widely used to treat erectile dysfunction (ED). However, this drug is associated with high frequency of adverse events such as headaches and cardiovascular disorders. "Vildegra" is a sildenafil encapsulated in hypromellose, which provides a slow release of the substance and a longer duration of action (13 hours vs. 4 hours). This may reduce the incidence of such effects.
AIM
To prove that Vildegra 50 mg has non-inferior efficiency compared to Viagra 50 mg, but is associated with better tolerability and greater safety.
MATERIALS AND METHODS
A triple-arm crossover open placebo-controlled randomized clinical trial was carried out in accordance with the protocol and all ethical principles. Patients were men aged 19-60 years with a diagnosis of ED. Patients received Vildegra as monotherapy within 4 weeks, followed by a week of a "washout" period, 4 weeks of placebo, another week of a "washout" period, then 4 weeks of Viagra. In the control group, the sequence of drugs was as following: Viagra - placebo - Vildegra.
RESULTS
"Vildegra" increased sexual activity 1.6 times more than "Viagra" and 2.4 times more than placebo. At the same time, there were no significant changes in the IIEF-5 score between "Vildegra" and "Viagra". The initial IIEF-5 score was 14+/-3.8 and 13.9+/-3.5, respectively, while after 1 month of therapy it improved to 20.9+/-3 and 20+/-3.4, respectively (p=0.678). The frequency of adverse events of "Vildegra" was 1.6…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.